 | • レポートコード：MRC2Q12-19115 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、HIV治療用医薬品のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 HIV治療用医薬品のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 HIV治療用医薬品の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 HIV治療用医薬品のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのHIV治療用医薬品の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のHIV治療用医薬品の売上および2028年までの予測に焦点を当てています。 HIV治療用医薬品のグローバル主要企業には、ViiV Healthcare、Gilead Sciences, Inc、AbbVie Inc.、Merck & Co、GSK、Bristol-Myers Squibb Company、Theratechnologies Inc.、Roche Holding AG、Teva Pharmaceuticals、Pfizer、Frontier Biotechnologies、Shionogi、Janssen Pharmaceuticals, Inc.、Mylan Pharmaceuticals Inc.、Genentech, Inc.、Boehringer Ingelheim、Cipla、MSDなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 HIV治療用医薬品市場は、タイプとアプリケーションによって区分されます。世界のHIV治療用医薬品市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 マルチタイプ併用医薬品、ヌクレオシド逆転写酵素阻害剤、非ヌクレオシド逆転写酵素阻害剤、HIV統合酵素連鎖移動阻害剤 【アプリケーション別セグメント】 病院、診療所、薬局 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - HIV治療用医薬品製品概要 - タイプ別市場（マルチタイプ併用医薬品、ヌクレオシド逆転写酵素阻害剤、非ヌクレオシド逆転写酵素阻害剤、HIV統合酵素連鎖移動阻害剤） - アプリケーション別市場（病院、診療所、薬局） - 調査の目的 ・エグゼクティブサマリー - 世界のHIV治療用医薬品販売量予測2017-2028 - 世界のHIV治療用医薬品売上予測2017-2028 - HIV治療用医薬品の地域別販売量 - HIV治療用医薬品の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別HIV治療用医薬品販売量 - 主要メーカー別HIV治療用医薬品売上 - 主要メーカー別HIV治療用医薬品価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（マルチタイプ併用医薬品、ヌクレオシド逆転写酵素阻害剤、非ヌクレオシド逆転写酵素阻害剤、HIV統合酵素連鎖移動阻害剤） - HIV治療用医薬品のタイプ別販売量 - HIV治療用医薬品のタイプ別売上 - HIV治療用医薬品のタイプ別価格 ・アプリケーション別市場規模（病院、診療所、薬局） - HIV治療用医薬品のアプリケーション別販売量 - HIV治療用医薬品のアプリケーション別売上 - HIV治療用医薬品のアプリケーション別価格 ・北米市場 - 北米のHIV治療用医薬品市場規模（タイプ別、アプリケーション別） - 主要国別のHIV治療用医薬品市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのHIV治療用医薬品市場規模（タイプ別、アプリケーション別） - 主要国別のHIV治療用医薬品市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のHIV治療用医薬品市場規模（タイプ別、アプリケーション別） - 主要国別のHIV治療用医薬品市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のHIV治療用医薬品市場規模（タイプ別、アプリケーション別） - 主要国別のHIV治療用医薬品市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのHIV治療用医薬品市場規模（タイプ別、アプリケーション別） - 主要国別のHIV治療用医薬品市場規模（トルコ、サウジアラビア） ・企業情報 ViiV Healthcare、Gilead Sciences, Inc、AbbVie Inc.、Merck & Co、GSK、Bristol-Myers Squibb Company、Theratechnologies Inc.、Roche Holding AG、Teva Pharmaceuticals、Pfizer、Frontier Biotechnologies、Shionogi、Janssen Pharmaceuticals, Inc.、Mylan Pharmaceuticals Inc.、Genentech, Inc.、Boehringer Ingelheim、Cipla、MSD ・産業チェーン及び販売チャネル分析 - HIV治療用医薬品の産業チェーン分析 - HIV治療用医薬品の原材料 - HIV治療用医薬品の生産プロセス - HIV治療用医薬品の販売及びマーケティング - HIV治療用医薬品の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - HIV治療用医薬品の産業動向 - HIV治療用医薬品のマーケットドライバー - HIV治療用医薬品の課題 - HIV治療用医薬品の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for HIV Therapy Drug is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for HIV Therapy Drug is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for HIV Therapy Drug is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of HIV Therapy Drug include ViiV Healthcare, Gilead Sciences, Inc, AbbVie Inc., Merck & Co, GSK, Bristol-Myers Squibb Company, Theratechnologies Inc., Roche Holding AG and Teva Pharmaceuticals, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the HIV Therapy Drug manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional HIV Therapy Drug market. Further, it explains the major drivers and regional dynamics of the global HIV Therapy Drug market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
ViiV Healthcare
Gilead Sciences, Inc
AbbVie Inc.
Merck & Co
GSK
Bristol-Myers Squibb Company
Theratechnologies Inc.
Roche Holding AG
Teva Pharmaceuticals
Pfizer
Frontier Biotechnologies
Shionogi
Janssen Pharmaceuticals, Inc.
Mylan Pharmaceuticals Inc.
Genentech, Inc.
Boehringer Ingelheim
Cipla
MSD
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
HIV Therapy Drug Segment by Type
Multi-Type Combined Drugs
Nucleoside Reverse Transcription Enzyme Inhibitors
Non-Nucleoside Reverse Transcription Enzyme Inhibitors
Hiv Integrated Enzyme Chain Transfer Inhibitor
HIV Therapy Drug Segment by Application
Hospital
Clinic
Pharmacy
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the HIV Therapy Drug market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for HIV Therapy Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of HIV Therapy Drug, also provides the sales of main regions and countries. Highlights of the upcoming market potential for HIV Therapy Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the HIV Therapy Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global HIV Therapy Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for HIV Therapy Drug sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including ViiV Healthcare, Gilead Sciences, Inc, AbbVie Inc., Merck & Co, GSK, Bristol-Myers Squibb Company, Theratechnologies Inc., Roche Holding AG and Teva Pharmaceuticals, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of HIV Therapy Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of HIV Therapy Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, HIV Therapy Drug sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 HIV Therapy Drug Product Introduction
1.2 Market by Type
1.2.1 Global HIV Therapy Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Multi-Type Combined Drugs
1.2.3 Nucleoside Reverse Transcription Enzyme Inhibitors
1.2.4 Non-Nucleoside Reverse Transcription Enzyme Inhibitors
1.2.5 Hiv Integrated Enzyme Chain Transfer Inhibitor
1.3 Market by Application
1.3.1 Global HIV Therapy Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global HIV Therapy Drug Sales Estimates and Forecasts 2017-2028
2.2 Global HIV Therapy Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global HIV Therapy Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global HIV Therapy Drug Sales by Region
2.4.1 Global HIV Therapy Drug Sales by Region (2017-2022)
2.4.2 Global Sales HIV Therapy Drug by Region (2023-2028)
2.5 Global HIV Therapy Drug Revenue by Region
2.5.1 Global HIV Therapy Drug Revenue by Region (2017-2022)
2.5.2 Global HIV Therapy Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global HIV Therapy Drug Sales by Manufacturers
3.1.1 Global Top HIV Therapy Drug Manufacturers by Sales (2017-2022)
3.1.2 Global HIV Therapy Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of HIV Therapy Drug in 2021
3.2 Global HIV Therapy Drug Revenue by Manufacturers
3.2.1 Global HIV Therapy Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global HIV Therapy Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by HIV Therapy Drug Revenue in 2021
3.3 Global HIV Therapy Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global HIV Therapy Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global HIV Therapy Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global HIV Therapy Drug Sales by Type
4.1.1 Global HIV Therapy Drug Historical Sales by Type (2017-2022)
4.1.2 Global HIV Therapy Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global HIV Therapy Drug Sales Market Share by Type (2017-2028)
4.2 Global HIV Therapy Drug Revenue by Type
4.2.1 Global HIV Therapy Drug Historical Revenue by Type (2017-2022)
4.2.2 Global HIV Therapy Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global HIV Therapy Drug Revenue Market Share by Type (2017-2028)
4.3 Global HIV Therapy Drug Price by Type
4.3.1 Global HIV Therapy Drug Price by Type (2017-2022)
4.3.2 Global HIV Therapy Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global HIV Therapy Drug Sales by Application
5.1.1 Global HIV Therapy Drug Historical Sales by Application (2017-2022)
5.1.2 Global HIV Therapy Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global HIV Therapy Drug Sales Market Share by Application (2017-2028)
5.2 Global HIV Therapy Drug Revenue by Application
5.2.1 Global HIV Therapy Drug Historical Revenue by Application (2017-2022)
5.2.2 Global HIV Therapy Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global HIV Therapy Drug Revenue Market Share by Application (2017-2028)
5.3 Global HIV Therapy Drug Price by Application
5.3.1 Global HIV Therapy Drug Price by Application (2017-2022)
5.3.2 Global HIV Therapy Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America HIV Therapy Drug Market Size by Type
6.1.1 North America HIV Therapy Drug Sales by Type (2017-2028)
6.1.2 North America HIV Therapy Drug Revenue by Type (2017-2028)
6.2 North America HIV Therapy Drug Market Size by Application
6.2.1 North America HIV Therapy Drug Sales by Application (2017-2028)
6.2.2 North America HIV Therapy Drug Revenue by Application (2017-2028)
6.3 North America HIV Therapy Drug Market Size by Country
6.3.1 North America HIV Therapy Drug Sales by Country (2017-2028)
6.3.2 North America HIV Therapy Drug Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe HIV Therapy Drug Market Size by Type
7.1.1 Europe HIV Therapy Drug Sales by Type (2017-2028)
7.1.2 Europe HIV Therapy Drug Revenue by Type (2017-2028)
7.2 Europe HIV Therapy Drug Market Size by Application
7.2.1 Europe HIV Therapy Drug Sales by Application (2017-2028)
7.2.2 Europe HIV Therapy Drug Revenue by Application (2017-2028)
7.3 Europe HIV Therapy Drug Market Size by Country
7.3.1 Europe HIV Therapy Drug Sales by Country (2017-2028)
7.3.2 Europe HIV Therapy Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific HIV Therapy Drug Market Size by Type
8.1.1 Asia Pacific HIV Therapy Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific HIV Therapy Drug Revenue by Type (2017-2028)
8.2 Asia Pacific HIV Therapy Drug Market Size by Application
8.2.1 Asia Pacific HIV Therapy Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific HIV Therapy Drug Revenue by Application (2017-2028)
8.3 Asia Pacific HIV Therapy Drug Market Size by Region
8.3.1 Asia Pacific HIV Therapy Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific HIV Therapy Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America HIV Therapy Drug Market Size by Type
9.1.1 Latin America HIV Therapy Drug Sales by Type (2017-2028)
9.1.2 Latin America HIV Therapy Drug Revenue by Type (2017-2028)
9.2 Latin America HIV Therapy Drug Market Size by Application
9.2.1 Latin America HIV Therapy Drug Sales by Application (2017-2028)
9.2.2 Latin America HIV Therapy Drug Revenue by Application (2017-2028)
9.3 Latin America HIV Therapy Drug Market Size by Country
9.3.1 Latin America HIV Therapy Drug Sales by Country (2017-2028)
9.3.2 Latin America HIV Therapy Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa HIV Therapy Drug Market Size by Type
10.1.1 Middle East and Africa HIV Therapy Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa HIV Therapy Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa HIV Therapy Drug Market Size by Application
10.2.1 Middle East and Africa HIV Therapy Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa HIV Therapy Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa HIV Therapy Drug Market Size by Country
10.3.1 Middle East and Africa HIV Therapy Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa HIV Therapy Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 ViiV Healthcare
11.1.1 ViiV Healthcare Corporation Information
11.1.2 ViiV Healthcare Overview
11.1.3 ViiV Healthcare HIV Therapy Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 ViiV Healthcare HIV Therapy Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 ViiV Healthcare Recent Developments
11.2 Gilead Sciences, Inc
11.2.1 Gilead Sciences, Inc Corporation Information
11.2.2 Gilead Sciences, Inc Overview
11.2.3 Gilead Sciences, Inc HIV Therapy Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Gilead Sciences, Inc HIV Therapy Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Gilead Sciences, Inc Recent Developments
11.3 AbbVie Inc.
11.3.1 AbbVie Inc. Corporation Information
11.3.2 AbbVie Inc. Overview
11.3.3 AbbVie Inc. HIV Therapy Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 AbbVie Inc. HIV Therapy Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 AbbVie Inc. Recent Developments
11.4 Merck & Co
11.4.1 Merck & Co Corporation Information
11.4.2 Merck & Co Overview
11.4.3 Merck & Co HIV Therapy Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Merck & Co HIV Therapy Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Merck & Co Recent Developments
11.5 GSK
11.5.1 GSK Corporation Information
11.5.2 GSK Overview
11.5.3 GSK HIV Therapy Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 GSK HIV Therapy Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GSK Recent Developments
11.6 Bristol-Myers Squibb Company
11.6.1 Bristol-Myers Squibb Company Corporation Information
11.6.2 Bristol-Myers Squibb Company Overview
11.6.3 Bristol-Myers Squibb Company HIV Therapy Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Bristol-Myers Squibb Company HIV Therapy Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bristol-Myers Squibb Company Recent Developments
11.7 Theratechnologies Inc.
11.7.1 Theratechnologies Inc. Corporation Information
11.7.2 Theratechnologies Inc. Overview
11.7.3 Theratechnologies Inc. HIV Therapy Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Theratechnologies Inc. HIV Therapy Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Theratechnologies Inc. Recent Developments
11.8 Roche Holding AG
11.8.1 Roche Holding AG Corporation Information
11.8.2 Roche Holding AG Overview
11.8.3 Roche Holding AG HIV Therapy Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Roche Holding AG HIV Therapy Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Roche Holding AG Recent Developments
11.9 Teva Pharmaceuticals
11.9.1 Teva Pharmaceuticals Corporation Information
11.9.2 Teva Pharmaceuticals Overview
11.9.3 Teva Pharmaceuticals HIV Therapy Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Teva Pharmaceuticals HIV Therapy Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Teva Pharmaceuticals Recent Developments
11.10 Pfizer
11.10.1 Pfizer Corporation Information
11.10.2 Pfizer Overview
11.10.3 Pfizer HIV Therapy Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Pfizer HIV Therapy Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Pfizer Recent Developments
11.11 Frontier Biotechnologies
11.11.1 Frontier Biotechnologies Corporation Information
11.11.2 Frontier Biotechnologies Overview
11.11.3 Frontier Biotechnologies HIV Therapy Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Frontier Biotechnologies HIV Therapy Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Frontier Biotechnologies Recent Developments
11.12 Shionogi
11.12.1 Shionogi Corporation Information
11.12.2 Shionogi Overview
11.12.3 Shionogi HIV Therapy Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Shionogi HIV Therapy Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Shionogi Recent Developments
11.13 Janssen Pharmaceuticals, Inc.
11.13.1 Janssen Pharmaceuticals, Inc. Corporation Information
11.13.2 Janssen Pharmaceuticals, Inc. Overview
11.13.3 Janssen Pharmaceuticals, Inc. HIV Therapy Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Janssen Pharmaceuticals, Inc. HIV Therapy Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Janssen Pharmaceuticals, Inc. Recent Developments
11.14 Mylan Pharmaceuticals Inc.
11.14.1 Mylan Pharmaceuticals Inc. Corporation Information
11.14.2 Mylan Pharmaceuticals Inc. Overview
11.14.3 Mylan Pharmaceuticals Inc. HIV Therapy Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Mylan Pharmaceuticals Inc. HIV Therapy Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Mylan Pharmaceuticals Inc. Recent Developments
11.15 Genentech, Inc.
11.15.1 Genentech, Inc. Corporation Information
11.15.2 Genentech, Inc. Overview
11.15.3 Genentech, Inc. HIV Therapy Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Genentech, Inc. HIV Therapy Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Genentech, Inc. Recent Developments
11.16 Boehringer Ingelheim
11.16.1 Boehringer Ingelheim Corporation Information
11.16.2 Boehringer Ingelheim Overview
11.16.3 Boehringer Ingelheim HIV Therapy Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Boehringer Ingelheim HIV Therapy Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Boehringer Ingelheim Recent Developments
11.17 Cipla
11.17.1 Cipla Corporation Information
11.17.2 Cipla Overview
11.17.3 Cipla HIV Therapy Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Cipla HIV Therapy Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Cipla Recent Developments
11.18 MSD
11.18.1 MSD Corporation Information
11.18.2 MSD Overview
11.18.3 MSD HIV Therapy Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 MSD HIV Therapy Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 MSD Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 HIV Therapy Drug Industry Chain Analysis
12.2 HIV Therapy Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 HIV Therapy Drug Production Mode & Process
12.4 HIV Therapy Drug Sales and Marketing
12.4.1 HIV Therapy Drug Sales Channels
12.4.2 HIV Therapy Drug Distributors
12.5 HIV Therapy Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 HIV Therapy Drug Industry Trends
13.2 HIV Therapy Drug Market Drivers
13.3 HIV Therapy Drug Market Challenges
13.4 HIV Therapy Drug Market Restraints
14 Key Findings in The Global HIV Therapy Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer